Highlights
About
Cannabis and Cannabinoid Pharmaceuticals
SciCann Therapeutics is a CanadianIsraeli pharmaceutical company that develops and commercializes pharmaceutical products that target and modulate the endocannabinoid system, including new therapeutic agents, drug candidates, novel cannabis genetics, and personalized treatment tools. SciCann Therapeutics is active in the fields of oncology, pain management, neurodegenerative diseases, and inflammatory disorders. The company develops a line of proprietary products for the treatment of chosen life-threatening conditions that present a high level of unmet need. SciCann Therapeutics holds a diversified portfolio of intellectual property and ownerships in ventures operating in cannabinoid science. It maintains a wide network of strategic and synergistic collaborations with research institutes and commercial companies in the space. The company's R&D is performed in Israel with commercialization in Canada.
Identity
| Name | SciCann Therapeutics |
|---|---|
| Slug | scicann-therapeutics |
| Type / kind | startup |
| Crunchbase ID | scicann-therapeutics-inc |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMjW1tUJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jul 2022 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Gan Ner |
| HQ address | Gan Ner, Israel |
Classifications
Funding
| Total raised | $3.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}